Advertisement

European Journal of Clinical Pharmacology

, Volume 59, Issue 2, pp 157–162 | Cite as

Inappropriate medication use among hospitalized older adults in Italy: results from the Italian Group of Pharmacoepidemiology in the Elderly

  • Graziano Onder
  • Francesco Landi
  • Matteo Cesari
  • Giovanni Gambassi
  • Pierugo Carbonin
  • Roberto Bernabei
  • on behalf of investigators of the GIFA Study
Pharmacoepidemiology and Prescription

Abstract

Objective

To determine the prevalence of inappropriate medication use among hospitalized older adults and to identify predictors of this use.

Methods

A total of 5734 patients (mean age 79 years) admitted to geriatric and internal medicine wards participating in the study in 1995 and 1997 were included in this analysis. Inappropriate medication use was defined on the basis of the criteria published by Beers in 1997. Only medications used during hospital stay were considered for the present study.

Results

During hospital stay, 837 (14.6%) patients received one or more medications classified as inappropriate based on Beers criteria. Ticlopidine (n=346; 6.0% of the study sample) was the most frequently used medication among those in Beers' list, followed by digoxin (n=174; 3.0%) and amytriptyline (n=113; 2.0%). The multivariate analysis showed that age [75–84 years vs 65–74 years, odds ratio (OR) 0.85, 95% confidence interval (CI) 0.71–1.00; ≥85 years vs 65–74 years, OR 0.58, 95% CI 0.46–0.73], cognitive impairment (OR 0.77, 95% CI 0.64–0.94), Charlson co-morbidity index (≥2 vs 0–1, OR 1.20, 95% CI 1.02–1.40) and overall number of medications used during hospital stay (5–8 medications vs <5 medications, OR 2.20, 95% CI 1.72–2.82; ≥9 medications vs <5 medications, OR 3.68, 95% CI 2.86–4.73) were significantly associated with use of inappropriate medications.

Conclusions

Inappropriate medication use was common among hospitalized older adults. The most important determinant of risk of receiving an inappropriate medication was the number of drugs being taken. Older age and cognitive impairment were associated with a reduced likelihood of using an inappropriate medication.

Keywords

Elderly Inappropriate medication use In-hospital patients 

Notes

Acknowledgements

The GIFA study was partially supported by a grant from the National Research Council (no. 94000402) and by Neopharmed.

References

  1. 1.
    Einarson TR (1993) Drug-related hospital admissions. Ann Pharmacother 27:832–840Google Scholar
  2. 2.
    Onder G, Pedone C, Landi F, Cesari M, Della Vedova C, Bernabei R, Gambassi G (2002) Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 50:1962–1968PubMedGoogle Scholar
  3. 3.
    Bordet R, Gautier S, Le Louet H, Dupuis B, Caron J (2001) Analysis of the direct cost of adverse drug reactions in hospitalised patients. Eur J Clin Pharmacol 56:935–941PubMedGoogle Scholar
  4. 4.
    Carbonin P, Pahor M, Bernabei R, Sgadari A (1991) Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? J Am Geriatr Soc 39:1093–1099Google Scholar
  5. 5.
    Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279:1200–1205PubMedGoogle Scholar
  6. 6.
    Everitt DE, Avorn J (1986) Drug prescribing for the elderly. Arch Intern Med 146:2393–2396CrossRefPubMedGoogle Scholar
  7. 7.
    Bates DW (1998) Drugs and adverse drug reactions: how worried should we be? JAMA 279:1216–1217Google Scholar
  8. 8.
    Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC (1991) Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 151:1825–1832PubMedGoogle Scholar
  9. 9.
    Stuck AE, Beers MH, Steiner A, Aronow HU, Rubenstein LZ, Beck JC (1994) Inappropriate medication use in community-residing older persons. Arch Intern Med 154:2195–2200Google Scholar
  10. 10.
    Beers MH (1997) Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 157:1531–1536Google Scholar
  11. 11.
    Aparasu RR, Mort JR (2000) Inappropriate prescribing for the elderly: beers criteria-based review. Ann Pharmacother 34:338–346PubMedGoogle Scholar
  12. 12.
    Willcox S, Himmelstein D, Woolhandler S (1994) Inappropriate drug prescribing for the community-dwelling elderly. JAMA 272:292–296PubMedGoogle Scholar
  13. 13.
    Beers MH, Ouslander JG, Fingold SF, Morgenstern H, Reuben DB, Rogers W, Zeffren MJ, Beck JC (1992) Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med 117:684–689PubMedGoogle Scholar
  14. 14.
    Spore D, Mor V, Larrat P, Hawes C, Hiris J (1997) Inappropriate drug prescriptions for elderly residents of board and care facilities. Am J Public Health 87:404–409PubMedGoogle Scholar
  15. 15.
    Aparasu R, Fliginger S (1997) Inappropriate medication prescribing for the elderly by office-based physicians. Ann Pharmacother 31:823–829PubMedGoogle Scholar
  16. 16.
    Aparasu R, Sitzman S (1999) Inappropriate prescribing for elderly outpatients. Am J Health Syst Pharm 56:433–439PubMedGoogle Scholar
  17. 17.
    Golden A, Preston R, Barnett S, Llorente M, Hamdan K, Silverman MA (1999) Inappropriate medication prescribing in homebound older adults. J Am Geriatr Soc 47:948–953PubMedGoogle Scholar
  18. 18.
    Pitkala KH, Strandberg TE, Tilvis RS (2002) Inappropriate drug prescribing in home-dwelling, elderly patients: a population-based survey. Arch Intern Med 162:1707–1712CrossRefPubMedGoogle Scholar
  19. 19.
    Grant RL, Batty GM, Aggarwal R, Lowe D, Potter JM, Pearson MG, Oborne A, Jackson SH (2002) National sentinel clinical audit of evidence-based prescribing for older people: methodology and development. J Eval Clin Pract 8:189–198CrossRefPubMedGoogle Scholar
  20. 20.
    Elliott RA, Woodward MC, Oborne CA (2001) Improving benzodiazepine prescribing for elderly hospital inpatients using audit and multidisciplinary feedback. Intern Med J 31:529–535CrossRefPubMedGoogle Scholar
  21. 21.
    Rochon PA, Gurwitz JH (1997) Optimising drug treatment for elderly people: the prescribing cascade. BMJ 315:1096–1099PubMedGoogle Scholar
  22. 22.
    Onder G, Landi F, Della Vedova C, Pedone C, Atkinson H, Cesari M, Bernabei R, Gambassi G (2002) Moderate alcohol consumption and adverse drug reactions among older adults. Pharmacoepidemiol Drug Saf 11:385–392CrossRefPubMedGoogle Scholar
  23. 23.
    Hodkinson HM (1972) Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing 1:233–238PubMedGoogle Scholar
  24. 24.
    Gomez de Caso JA, Rodriguez-Artalejo F, Claveria LE, Coria F (1994) Value of Hodkinson's test for detecting dementia and mild cognitive impairment in epidemiological surveys. Neuroepidemiology 13:64–68PubMedGoogle Scholar
  25. 25.
    Rocca WA, Bonaiuto S, Lippi A, Luciani P, Pistarelli T, Grandinetti A, Cavarzeran F, Amaducci L (1992) Validation of the Hodkinson abbreviated mental test as a screening instrument for dementia in an Italian population. Neuroepidemiology 11:288–295PubMedGoogle Scholar
  26. 26.
    Pahor M, Chrischilles EA, Guralnik JM, Brown SL, Wallace RB, Carbonin PU (1994) Drug data coding and analysis in epidemiological studies. Eur J Epidemiol 10:405–411PubMedGoogle Scholar
  27. 27.
    PHS-HCFA (1980) International classification of diseases, 9th rev. Public Health Service-Health Care Financing Administration, WashingtonGoogle Scholar
  28. 28.
    Charlson ME, Pompei P, Ales KL, Mackenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40:373–383Google Scholar
  29. 29.
    Avorn J (2001) Improving drug use in elderly patients: getting to the next level. JAMA 286:2866–2868CrossRefPubMedGoogle Scholar
  30. 30.
    Gurwitz JH, Rochon P (2002) Improving the quality of medication use in elderly patients: a not-so-simple prescription. Arch Intern Med 162:1670–1672CrossRefPubMedGoogle Scholar
  31. 31.
    Cerbone AM, Tufano A, Di Minno G (2000) Linee Guida di terapia antitrombotica nel paziente anziano. Giorn Geront 48:419–433Google Scholar
  32. 32.
    Onder G, Gambassi G, Scales CJ, Cesari M, Della Vedova C, Landi F, Bernabei R (2002) Adverse drug reactions and cognitive function among hospitalized older adults. Eur J Clin Pharmacol 58:371–377CrossRefPubMedGoogle Scholar
  33. 33.
    Lawson DH, Jick H (1976) Drug prescribing in hospitals: an international comparison. Am J Public Health 66:644–648PubMedGoogle Scholar
  34. 34.
    Gambassi G, Forman DE, Lapane KL, Mor V, Sgadari A, Lipsitz LA, Bernabei R (2000) Management of heart failure among very old persons living in long-term care: has the voice of trials spread? The SAGE Study Group. Am Heart J 139:85–93CrossRefPubMedGoogle Scholar
  35. 35.
    Onder G, Gambassi G, Landi F, Pedone C, Cesari M, Carbonin PU, Bernabei R (2001) Trends in antihypertensive drugs in the elderly: the decline of thiazides. J Hum Hypertens 15:291–297Google Scholar
  36. 36.
    Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Kader B, Moskowitz MA (1998) Inadequate management of blood pressure in a hypertensive population. N Engl J Med 339:1957–1963Google Scholar
  37. 37.
    Onder G, Pedone C, Gambassi G, Landi F, Cesari M, Bernabei R (2001) Temporal patterns in medical treatment of osteoporosis among elderly patients in Italy. Eur J Clin Pharmacol 57:599–604PubMedGoogle Scholar
  38. 38.
    Bernabei R, Gambassi G, Lapane K, Landi F, Gatsonis C, Dunlop R, Lipsitz L, Steel K, Mor V (1998) Management of pain in elderly patients with cancer. SAGE Study Group. Systematic assessment of geriatric drug use via epidemiology. JAMA 279:1877–1882CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • Graziano Onder
    • 1
    • 2
  • Francesco Landi
    • 1
  • Matteo Cesari
    • 1
    • 2
  • Giovanni Gambassi
    • 1
  • Pierugo Carbonin
    • 1
  • Roberto Bernabei
    • 1
  • on behalf of investigators of the GIFA Study
  1. 1.Centro Medicina dell'InvecchiamentoUniversità Cattolica del Sacro Cuore, Policlinico A. GemelliRomaItaly
  2. 2.Section of Gerontology and GeriatricsWake Forest University, Baptist Medical CenterWinston SalemUSA

Personalised recommendations